Title : A global treatments for coronaviruses including COVID-19.

Pub. Date : 2020 Dec

PMID : 32394467






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Neuraminidase inhibitors such as oseltamivir, peramivir, and zanamivir are invalid for 2019-nCoV and are not recommended for treatment but protease inhibitors such as lopinavir/ritonavir (LPV/r) inhibit the progression of MERS-CoV disease and can be useful for patients of COVID-19 and, in combination with Arbidol, has a direct antiviral effect on early replication of SARS-CoV. umifenovir neuraminidase 1 Homo sapiens